Led the transformation of market access and pricing strategies, embedding data-driven decision-making and AI-driven analytics to optimize payer engagement and pricing models. Established Real-World Evidence (RWE) and Big Data Platforms, leveraging digital tools to create a tech-enabled value framework for payers, regulators, and policy stakeholders. Spearheaded the development of precision medicine-focused launch strategies, utilizing machine learning and predictive analytics to refine pricing and market access models. Built and led a high-performing global team, driving collaboration across Field MSL, HEOR, RWE, and Strategic Account Management functions. Designed patient-centric access pathways, aligning with regulatory, medical, and commercial teams to ensure value-driven pricing and reimbursement solutions. Focused on US, EU5, Japan, and China, while pioneering innovative access frameworks for emerging markets. Indivior, VP, Global Head, Market Access & Strategic Planning Oct 2017 - Jul 2020 Pioneered market expansion strategies, integrating real-world data to develop cost-effective access solutions. Strengthened internal capabilities in pricing analytics, HEOR modeling, and policy engagement to address payer needs for behavioral and mental health therapies. Developed cross-functional digital engagement strategies to improve payer interaction and decision-making in key markets. Directed BD&L efforts, driving data-backed investment decisions for asset acquisition and pipel

Led global and regional teams to implement innovative market access strategies, ensuring successful product launches in the US, EMEA, Japan, and RoW. Implemented AI-powered forecasting models, improving pricing accuracy and access execution across key markets.

Restructured and expanded the market access team, integrating digital tools for real-time tracking of pricing and reimbursement trends. Led the development of automated HEOR and HTA analysis frameworks, streamlining data utilization for evidence-based decision-making. Achieved Presidents Awards for pioneering innovative access models and policy engagements.

Held pivotal roles in Medical Affairs, Sales, and New Product Planning, implementing data-driven commercial strategies that enhanced market penetration and patient access. Designed integrated digital platforms for clinical trial data analysis and real-time engagement with key stakeholders.